K2X Technology & Life Science, Inc.
KBPH
OTC PK
| 12/31/2021 | 09/30/2021 | 06/30/2021 | 03/31/2021 | 12/31/2020 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | 86.84% | -100.00% |
| Total Revenue | -- | -- | -- | 86.84% | -100.00% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | 86.84% | -100.00% |
| SG&A Expenses | 7.09% | 68.55% | 1,194.57% | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 13.49% | 154.40% | 748.65% | -48.35% | 167.18% |
| Total Operating Expenses | 11.72% | 120.30% | 894.34% | -48.35% | 268.85% |
| Operating Income | -11.72% | -120.30% | -894.34% | 48.76% | -309.73% |
| Income Before Tax | 8,105.00% | 213.14% | -758.10% | 142.04% | 95.57% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 8,105.00% | 213.14% | -758.10% | 142.04% | 95.57% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 8,105.00% | 213.14% | -758.10% | 142.04% | 95.57% |
| EBIT | -11.72% | -120.30% | -894.34% | 48.76% | -309.73% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 2,940.00% | 37.80% | -276.12% | 134.89% | 96.77% |
| Normalized Basic EPS | 28.28% | 2.34% | -333.33% | 45.48% | -151.55% |
| EPS Diluted | 2,100.00% | 100.00% | -276.12% | 104.20% | 96.77% |
| Normalized Diluted EPS | 8.33% | -44.64% | -333.33% | 89.41% | -11.34% |
| Average Basic Shares Outstanding | 55.81% | 127.38% | 127.33% | 20.33% | 46.11% |
| Average Diluted Shares Outstanding | 22.02% | 51.99% | 127.33% | 516.10% | 230.18% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
